BIIB card
BIIB price forecast
Biogen$251,65
P/E now is 108,5. Average over 5 years: 22,0 (range 14–23). The stock is 392% above its history.
Base · FY2030
$205,19−4,8% a year
The base case gives −4,8% a year, below your target of 10%.
Settings
%
No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.
Calculated from your assumptions. Not an investment recommendation.
Base · FY2030$205,19−4,8% a year